Tuberculosis Antimicrobial Stewardship Program (TASP): tackling Bedaquiline-resistant tuberculosiscore
TASP · Horizon Europe grant · 2025-06-01–2030-05-31
EC contribution
Total cost
Beneficiaries
About the data
Source: CORDIS (official EU open data), Horizon Europe. Framework HORIZON · call HORIZON-JU-GH-EDCTP3-2024-01-two-stage · scheme HORIZON-JU-RIA · topic HORIZON-JU-GH-EDCTP3-2024-01-04-two-stage. CORDIS record →
Objective
In the 2024 updated Bacterial Priority Pathogen list of WHO, Mycobacterium tuberculosis (TB) is a critical priority pathogen, emphasizing the urgent need for action. Rifampicin resistant-tuberculosis (Rr-TB) is estimated to cause 13% of antimicrobial resistance-attributable deaths globally and is driven by both ongoing resistance acquisition and person-to-person transmission. Bedaquiline (BDQ), a new drug, is strongly recommended for Rr-TB treatment since 2018. In this very short time, BDQ resistance has proliferated significantly. For Rr-TB at risk of/with BDQ resistance (BDQr/Rr-TB) there is no evidence-based regimen. The current practice, with continued failing regimens, imperils the potency of the remaining Rr-TB drug arsenal.Tuberculosis Antimicrobial Stewardship Program (TASP) aims to rapidly reduce bacillary load in patients at risk/with BDQr/Rr-TB by using an empirical highly bactericidal intensive phase (for those at risk) followed by drug-susceptibility testing (DST)-informed artificial intelligence (AI)-aided Treatment Recommender's regimen composition. 125 participants at risk/with BDQr/Rr-TB will be enrolled in Nigeria, Mozambique and South Africa. Baseline and acquired resistance will be monitored and a novel, fast and quantitative phenotypic method (thin layer agar), with little infrastructural requirements, will be evaluated in TASP’s high burden, limited resource settings through decentralized implementation. Additionally, TASP will improve environmental control with co-designed, portable air cleaners, built sourcing low-cost materials from the local market. Filter waste products will be used for resistance surveillance and compared to conventional bio-aerosol samplers.The anticipated impact of TASP is a cost-effective TB antimicrobial stewardship programme that reduces further resistance development and salvages the current all-oral BDQ regimens for the future.
Beneficiaries (12)
| Organisation | Country | Role | EC contribution | SME |
|---|---|---|---|---|
| INSTITUUT VOOR TROPISCHE GENEESKUNDE | BE | coordinator | €1,255,416 | |
| THE AURUM INSTITUTE NPC | ZA | participant | €878,259 | |
| CENTRE NATIONAL HOSPITALIER DE PNEUMO-PHTISIOLOGIE | BJ | participant | €820,699 | |
| UNIVERSITY OF IBADAN | NG | participant | €736,342 | |
| FUNDACAO AURUM | MZ | participant | €690,781 | |
| UNIVERSITY OF RWANDA | RW | participant | €583,547 | |
| UNIVERSITY OF CAPE TOWN | ZA | participant | €434,989 | |
| STICHTING VU | NL | participant | €215,625 | |
| LAGOS STATE UNIVERISTY OF SCIENCE AND TECHNOLOGY | NG | participant | €130,520 | |
| UPPSALA UNIVERSITET | SE | participant | €124,250 | |
| UNIVERSITEIT ANTWERPEN | BE | participant | €71,500 | |
| THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO | CA | participant | €58,062 |
Get the EU Defence Funding Calendar — free
The full calendar of open EU defence and dual-use funding calls, sorted by deadline, updated nightly. Delivered with DFM Analysis, our weekly briefing on who is funding what in European defence.
Or browse all open defence & dual-use calls on the funding calendar →
Defence Finance Monitor is an analytical and informational product. Grant data is official CORDIS; the paid Annual Professional subscription is handled on DFM Analysis.